A Phase 3 US Multicenter Randomized Controlled Trial Evaluating Efficacy of a Perivascularly Delivered Sirolimus Formulation (Sirogen™) for Improving Hemodialysis AVF Outcomes
Publication/Presentation Date
10-2021
Volume
32
Issue
10S
Published In/Presented At
DeVita, Maria V.1; Kopyt, Nelson P.2; Khawar, Osman3; Atray, Naveen K.4; Gandhi, Nirav5; Hendon, Kendra S.6; Lynn, Robert I.7; Iyer, Sriram8,9; On behalf of the ACCESS Trial Investigators. ACCESS (NCT02513303): A Phase 3 US Multicenter Randomized Controlled Trial Evaluating Efficacy of a Perivascularly Delivered Sirolimus Formulation (Sirogen™) for Improving Hemodialysis AVF Outcomes: PO2532. Journal of the American Society of Nephrology 32(10S):p B7, October 2021. | DOI: 10.1681/ASN.20213210S1B7a
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS